SavedAdd your journal

Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 3 Issue: Supplement 1 Special Issue

Coexistence of Medullary and Papillary Thyroid Carcinomas Detected Incidentally

Ensar Aydemir(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0001-8519-784X
Özen Öz Gül(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0002-1332-4165
Yasemin Aydoğan Ünsal(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0002-1566-3099
Coşkun Ateş(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0003-4565-9848
Soner Cander(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0001-6303-7896
Canan Ersoy(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0003-4510-6282
Erdinç Ertürk(ULUDAG UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, ENDOCRINOLOGY AND METABOLIC DISEASES)0000-0003-2399-6608
Pages
—
Publication Date
2021-03-07
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, the prevelance and characteristics of 8 patients with simultaneous PTC and MTC diagnoses were evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Papillary thyroid carcinoma (PTC) and Medullary thyroid carcinoma (MTC) are extremely rare and constitute less than 0.5% of all thyroid malignancies.
📊
Key Findings & Data:Papillary thyroid carcinoma (PTC) and Medullary thyroid carcinoma (MTC) are extremely rare and constitute less than 0.5% of all thyroid malignancies.
💡
Conclusion & Impact:In this study, the prevelance and characteristics of 8 patients with simultaneous PTC and MTC diagnoses were evaluated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Germline RET mutation · Papillary thyroid carcinoma · Medullary thyroid carcinoma

Abstract

Papillary thyroid carcinoma (PTC) and Medullary thyroid carcinoma (MTC) are extremely rare and constitute less than 0.5% of all thyroid malignancies. In this study, the prevelance and characteristics of 8 patients with simultaneous PTC and MTC diagnoses were evaluated.

🔖

Cite This Article

Aydemir, E., Gül, Ö. Ö., Ünsal, Y. A., Ateş, C., Cander, S., Ersoy, C., Ertürk, E. (2021). Coexistence of Medullary and Papillary Thyroid Carcinomas Detected Incidentally. Turkish Journal of Internal Medicine, Volume: 3 Issue: Supplement 1 Special Issue. https://doi.org/10.46310/tjim.882858

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute. Available at: https://seer.cancer.gov/explorer/. Accessed September 14, 2020.
  2. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011 Mar;5(1):51-6. doi: 10.1007/s12105-010-0236-9.
  3. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
  4. Bayrak E, Serter R. Coexistence of papillary and medullary thyroid carcinoma: A rare entity. The Turkish Journal of Endocrinology and Metabolism. 2020;24:168-72. doi: 10.25179/tjem.2019-72499.
  5. Biscolla RP, Ugolini C, Sculli M, Bottici V, Castagna MG, Romei C, Cosci B, Molinaro E, Faviana P, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior. Thyroid. 2004 Nov;14(11):946-52. doi: 10.1089/thy.2004.14.946.
  6. Kim WG, Gong G, Kim EY, Kim TY, Hong SJ, Kim WB, Shong YK. Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf). 2010 Feb;72(2):256-63. doi: 10.1111/j.1365-2265.2009.03622.x.
  7. Machens A, Dralle H. Simultaneous medullary and papillary thyroid cancer: a novel entity?. Ann Surg Oncol. 2012 Jan;19(1):37-44. doi: 10.1245/s10434-011-1795-z.
  8. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
  9. Appetecchia M, Lauretta R, Barnabei A, Pieruzzi L, Terrenato I, Cavedon E, Mian C, Castagna MG, Elisei R; SIE (Italian Society of Endocrinology) Working Group. Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC/PTC): An Italian multicenter study. Cancers (Basel). 2019 Oct 9;11(10):1516. doi: 10.3390/cancers11101516.